Zepp Health Return on Tangible Equity 2017-2025 | ZEPP
Current and historical return on tangible equity values for Zepp Health (ZEPP) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Zepp Health Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-06-30 | $-0.08B | $0.20B | -33.12% |
| 2025-03-31 | $-0.08B | $0.21B | -30.98% |
| 2024-12-31 | $-0.08B | $0.24B | -26.32% |
| 2024-09-30 | $-0.04B | $0.30B | -12.78% |
| 2024-06-30 | $-0.03B | $0.31B | -8.45% |
| 2024-03-31 | $-0.03B | $0.32B | -8.02% |
| 2023-12-31 | $-0.03B | $0.33B | -9.36% |
| 2023-09-30 | $-0.04B | $0.32B | -11.52% |
| 2023-06-30 | $-0.04B | $0.32B | -11.76% |
| 2023-03-31 | $-0.05B | $0.35B | -12.91% |
| 2022-12-31 | $-0.04B | $0.36B | -10.76% |
| 2022-09-30 | $-0.02B | $0.36B | -6.07% |
| 2022-06-30 | $-0.03B | $0.39B | -6.99% |
| 2022-03-31 | $0.01B | $0.41B | 1.75% |
| 2021-09-30 | $0.03B | $0.42B | 8.53% |
| 2021-03-31 | $0.03B | $0.38B | 7.39% |
| 2020-12-31 | $0.04B | $0.39B | 10.13% |
| 2020-09-30 | $0.05B | $0.36B | 13.61% |
| 2020-06-30 | $0.06B | $0.33B | 18.90% |
| 2020-03-31 | $0.07B | $0.35B | 23.02% |
| 2019-12-31 | $0.08B | $0.35B | 27.06% |
| 2019-09-30 | $0.04B | $0.31B | 13.23% |
| 2019-06-30 | $0.03B | $0.29B | 9.51% |
| 2019-03-31 | $0.03B | $0.27B | 10.11% |
| 2018-12-31 | $0.02B | $0.25B | 6.87% |
| 2018-09-30 | $0.04B | $0.24B | 23.60% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.585B | $0.183B |
| Zepp Health Corp. developed a platform of proprietary technology including AI chips, biometric sensors and health data algorithms, which drive a broadening line of smart health products for consumers and analytics services for insurers, healthcare providers, employers, drug and treatment companies. Zepp Health Corp., formerly known as Huami Corporation, is based in CUPERTINO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.824B | 59.57 |
| Tempus AI (TEM) | United States | $13.255B | 0.00 |
| Doximity (DOCS) | United States | $12.564B | 55.90 |
| Hims & Hers Health (HIMS) | United States | $10.250B | 83.98 |
| IRhythm Technologies (IRTC) | United States | $5.398B | 0.00 |
| Hinge Health (HNGE) | United States | $4.325B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.713B | 39.89 |
| Privia Health (PRVA) | United States | $2.625B | 194.46 |
| Heartflow (HTFL) | $2.547B | 0.00 | |
| Phreesia (PHR) | United States | $1.833B | 0.00 |
| Enovis (ENOV) | United States | $1.782B | 9.42 |
| 10x Genomics (TXG) | United States | $1.747B | 0.00 |
| Omnicell (OMCL) | United States | $1.503B | 28.96 |
| Schrodinger (SDGR) | United States | $1.446B | 0.00 |
| Azenta (AZTA) | United States | $1.401B | 61.14 |
| Clover Health Investments (CLOV) | United States | $1.368B | 0.00 |
| Claritev (CTEV) | United States | $1.196B | 0.00 |
| Evolent Health (EVH) | United States | $1.089B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.657B | 0.00 |
| Veradigm (MDRX) | United States | $0.536B | 0.00 |
| Standard BioTools (LAB) | United States | $0.493B | 0.00 |
| Talkspace (TALK) | United States | $0.447B | 133.50 |
| Butterfly Network (BFLY) | United States | $0.400B | 0.00 |
| Carlsmed (CARL) | United States | $0.365B | 0.00 |
| TruBridge (TBRG) | United States | $0.300B | 52.66 |
| Outset Medical (OM) | United States | $0.251B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.246B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.228B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.218B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.197B | 0.00 |
| CapsoVision (CV) | United States | $0.184B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.171B | 0.00 |
| CareCloud (CCLD) | United States | $0.156B | 7.08 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.127B | 0.00 |
| American Well (AMWL) | United States | $0.113B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.084B | 0.00 |
| Pulmonx (LUNG) | United States | $0.072B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.072B | 0.00 |
| 111 (YI) | China | $0.061B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.057B | 0.00 |
| HeartBeam (BEAT) | United States | $0.039B | 0.00 |
| Zhongchao (ZCMD) | China | $0.025B | 0.00 |
| Precipio (PRPO) | United States | $0.023B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.016B | 0.00 |
| PROFUSA (PFSA) | United States | $0.014B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.005B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |